IlluminOss Medical

The world’s first and only patient-conforming, photodynamic intramedullary implant for osteoporotic and fragility fractures

Overview

Founded in 2007, IlluminOss Medical offers the world’s first and only minimally invasive, patient-specific intramedullary fracture fixation implant. The IlluminOss system comprises a liquid monomer contained within expandable balloon and cured via visible light into rigid, patient-conforming intramedullary implant, ideal for osteoporotic and weakened bone. The revolutionary procedure is made through a minimally invasive surgical approach, providing patients and clinicians with a fast, patient-specific method for bone stabilization, unparalleled surgical flexibility and fast return to daily activities. With over 15,000 implantations (and counting) and over 40 clinical publications to date, IlluminOss is rapidly becoming the standard of care for fragility and pathologic fractures, and as a unique solution in highly complex periprosthetic fractures.

HealthpointCapital identified IlluminOss as part of a proactive search for disruptive innovation in the rapidly growing orthogeriatric trauma market. As a result of the orthopedic industry expertise of our team, HealthpointCapital was able to rapidly develop a productive relationship with the management and investor team at IlluminOss and complete the deal on an exclusive negotiated basis.